Jørn Brynskov Selected Research

Varicella Zoster Encephalitis (Encephalitis, Varicella)

1/2022

Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to Tofacitinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jørn Brynskov Research Topics

Disease

25	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2022 - 01/2009
23	Crohn Disease (Crohn's Disease) 01/2019 - 04/2008
15	Ulcerative Colitis 11/2022 - 02/2006
4	Necrosis 11/2015 - 01/2009
3	Inflammation (Inflammations) 12/2015 - 10/2010
2	Adenoma (Adenomas) 12/2015 - 02/2005
1	Hemorrhage 03/2022
1	Fatigue 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Varicella Zoster Encephalitis (Encephalitis, Varicella) 01/2022
1	Pain (Aches) 01/2022
1	Infections 11/2021
1	Spontaneous Abortion (Miscarriage) 11/2021
1	Body Weight (Weight, Body) 01/2021
1	Hypersensitivity (Allergy) 01/2017
1	Pathologic Constriction (Stenosis) 03/2016
1	Communicable Diseases (Infectious Diseases) 11/2015
1	Anaphylaxis (Anaphylactic Shock) 02/2012
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 02/2012
1	Fistula 09/2011
1	Colitis 07/2010
1	Arthralgia (Joint Pain) 02/2006
1	Arthritis (Polyarthritis) 02/2006
1	Disease Progression 02/2006
1	Type 2 Diabetes Mellitus (MODY) 02/2005
1	Polyps 02/2005
1	Neoplasms (Cancer) 02/2005
1	Carcinogenesis 02/2005

Drug/Important Bio-Agent (IBA)

27	Infliximab (Remicade)FDA Link 03/2022 - 04/2008
14	AntibodiesIBA 01/2022 - 04/2008
7	Pharmaceutical PreparationsIBA 01/2022 - 02/2006
5	Adalimumab (Humira)FDA Link 01/2018 - 02/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 04/2008
3	Tumor Necrosis Factor InhibitorsIBA 01/2016 - 10/2010
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	2-mercaptopurineIBA 02/2018 - 01/2018
2	Fluorescein (Funduscein)FDA LinkGeneric 08/2016 - 04/2016
2	Biological ProductsIBA 01/2016 - 10/2010
2	EnzymesIBA 01/2016 - 09/2011
2	Phenobarbital (Luminal)FDA Link 12/2014 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 09/2011 - 01/2009
2	PPAR gammaIBA 07/2010 - 02/2005
2	LigandsIBA 07/2010 - 02/2005
2	Messenger RNA (mRNA)IBA 01/2009 - 02/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Azathioprine (Imuran)FDA LinkGeneric 03/2022
1	Allopurinol (Remid)FDA LinkGeneric 03/2022
1	SteroidsIBA 03/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	tofacitinibIBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	vedolizumabIBA 11/2021
1	AlbuminsIBA 01/2021
1	NucleotidesIBA 02/2018
1	Thioguanine (Tioguanine)FDA Link 02/2018
1	25-hydroxyvitamin DIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	CytokinesIBA 04/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011
1	Peptide Hydrolases (Proteases)FDA Link 09/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010
1	Mesalamine (Mesalazine)FDA LinkGeneric 07/2010
1	Rosiglitazone (Avandia)FDA Link 07/2010
1	Toll-Like Receptor 8IBA 01/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2009
1	Etanercept (Enbrel)FDA Link 01/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2006
1	Celecoxib (Celebrex)FDA Link 02/2006
1	PPAR alphaIBA 02/2005
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2005

Therapy/Procedure

22	Therapeutics 11/2022 - 02/2006
3	Lasers (Laser) 08/2016 - 12/2015
3	Activities of Daily Living (ADL) 01/2016 - 10/2014
2	Biological Therapy 03/2022 - 01/2022
2	Colectomy 08/2015 - 12/2010
1	Conscious Sedation 01/2022
1	Stents 03/2016
1	Retreatment 05/2012
1	Enema (Enemas) 07/2010
1	Drug Therapy (Chemotherapy) 02/2006